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INTRODUCTION
CT has been the main imaging modality for the detection, 
characterization and follow-up of lung nodules, and lung 
nodules are the major radiologic fi  nding of primary and 
metastatic lung cancers. These tasks have traditionally 
been performed by a combination of visual assessment and 
manual measurement by radiologists; however, the advances 
in CT technology in recent years have enabled newer and 
better performance in this endeavor with the development 
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of 3D volumetric imaging as well as numerous post-
processing techniques. Further, with the advent of picture 
archiving and communication systems (PACS), access to 
digital images is now easier and faster than ever before. 
This unprecedented wealth of digital images has led to the 
development of computer-aided diagnosis (CAD) for the 
evaluation of lung nodules. 
A good indication for applying CAD can be seen in the 
use of low-dose CT during lung cancer screening, which 
is typically a repetitive and burdensome task of dealing 
with mostly normal images. As a large proportion of the 
nodules detected on screening CT are smaller than 4 mm 
in diameter and most of them are benign, determining the 
malignancy of nodules by nodule characterization is crucial. 
Nodule growth, which is expressed as the volume doubling 
time, can be an important discriminator for this purpose. In 
addition to the screening setting, CAD can also be applied 
to various oncologic settings for identifying metastatic 
lung nodules as well as monitoring the therapy for lung 
metastasis. 
The goals of CAD for the evaluation of lung nodules 
are to assist radiologists in detecting lung nodules, Korean J Radiol 12(2), Mar/Apr 2011 www.kjronline.org 146
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differentiating benign from malignant nodules, monitoring 
the treatment response and enhancing the workfl  ow. The 
purpose of this article is to review the current status of CAD 
in the evaluation of lung nodules and to suggest its future 
directions.
Nodule Detection
Computer-Aided Diagnosis Performance
In terms of spatial and contrast resolution, CT is currently 
the best imaging modality for evaluating lung nodules. 
However, lung nodules on chest CT, and especially those 
smaller than 5 mm, can easily be missed by the reader when 
using visual assessment alone. CAD has been shown in many 
studies to be able to improve radiologists’ performance 
for detecting these lung nodules (1-7) (Fig. 1). Many 
investigators have reported a wide range of sensitivities 
using CAD from 54% to 95% with false positive rates of 
0.55 to 8.3 per examination for detecting lung nodules 
(3-4, 6-13) (Table 1). However, it is diffi  cult to compare 
the results of CAD’s performance from the various studies 
as most of the performances were evaluated with different 
data sets, and particularly a different size database, the 
different nature and characteristics of the nodules and 
various evaluation methods, as well as the differences in 
the employed CAD algorithm. In addition, the standard 
of reference for the presence of nodule in most previous 
studies was usually determined by an expert panel, and this 
Fig. 1. Snapshot of computer-aided 
diagnosis output for lung nodule. 
Detected nodule is marked with circle, 
and information about nodule size is 
present in bottom of left panel. Magnifi  ed 
views of detected nodule are presented 
in right panel with color overlay to show 
segmentation results.
Table 1. Summary of Published Studies on Performance of CAD Systems for Detecting Lung Nodules
Author (Reference No.) Year No. of Nodules CAD Sensitivity False Positive Rate CT Section Thickness Nodule Size
McCulloch et al. (8) 2004 43 70% 8.3 2.5 mm 5-17.1 mm
Marten et al. (11) 2005 135 76% 0.55 0.75 mm 1-29.6 mm
Lee et al. (10) 2005 78 60% 1.56 2.5 mm 4-15.4 mm
Bae et al. (9) 2005 164 95% 6.9 1.0 mm 3-27 mm
Yuan et al. (13) 2006 628 73% 3.19 1.25 mm -
Das et al.* (12) 2006 116
73%
75%
6
8
1-2 mm Mean, 3.4 mm
Beigelman-Aubry et al. (3) 2007 52 65% 3.4 1.25 mm 4-11.9 mm
Goo et al. (4) 2008 352 80% 2.96 1-3.2 mm < 18 mm
Hirose et al. (6) 2008 49 71% 0.95 1 mm 2.3-12.0 mm
Sahiner et al. (7) 2009 241 54% 5.6 1.25-3 mm 3-18.6 mm
Note.— *Two CAD systems were evaluated using same dataset. CAD = computer-aided diagnosis, No. = number Korean J Radiol 12(2), Mar/Apr 2011 www.kjronline.org 147
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determination may be subjective. Substantial variability 
has been reported in establishing a “truth” reference for 
identifying nodules on CT scans (14). 
The scan and reconstruction parameters of CT and the 
number of false positive detections are also important 
factors. In general, the sensitivity can be increased at the 
cost of increasing the number of false positive detections. 
Das et al. (12) compared the effects of two commercial 
CAD systems with using the same dataset, and the overall 
sensitivities for each system were 73% and 75% with false 
positive rates of 6% and 8%, respectively.
There have been several studies that have compared the 
performance of radiologists and CAD (11, 15). These studies 
have shown that the CAD system performs the nodule 
detection task differently from that of a radiologist. In a 
study by Lee et al. (15), the sensitivity of the CAD system 
for detecting isolated nodules was signifi  cantly higher than 
that of a radiologist, while the sensitivities of a radiologist 
for detecting nodules > 5 mm and nodules attached to 
other structures were higher than those of the CAD system. 
Similarly, Marten et al. (11) showed that detection of 
nodules 5 mm or less in diameter was signifi  cantly higher 
for a CAD system than that for readers. In addition, while 
the CAD system detected more nodules that were without 
vascular attachment, the readers detected more nodules 
with vascular attachment (Fig. 2). If we may sum up these 
fi  ndings, in general, a CAD system is good at detecting 
isolated and small nodules, while radiologists are better at 
detecting attached and relatively larger nodules. 
It has been shown that for detecting nodules, CAD can 
assist observers more effectively than a second reader, and 
therefore the combined performance of radiologists with 
CAD may be better than that of a double reading. In one 
such study by Rubin et al. (16), the mean sensitivity for an 
individual reading was 50% and a double reading resulted 
in an increase to 63%. Yet with CAD, by setting a threshold 
of three false positive detections per CT scan, the mean 
sensitivity was able to be increased to 76%.
However, high sensitivity has been known to be highly 
related to the number of false positive markings. As 
rejecting the numerous false positive markings generated 
by the CAD system is time consuming, the number of 
false positive markings should always be a consideration. 
Although there is no consensus on the acceptable false 
positive rate, fi  ve or less false positive detections per case 
would be acceptable because the false positive marks when 
detecting lung nodule with CAD are usually easy to reject. 
Various features may cause a false positive marking such as 
scars, bronchial wall thickening, vessel bifurcations, motion 
artifacts and inadequate segmentation of the mediastinal 
structures (Fig. 3).
As for the time required to perform CAD, in a study by 
Beigelman-Aubry et al. (3), the overall reading time on 
the CAD workstation and the clinical workstation was 
comparable. The average time required to assess all the CAD 
marks per case was 39 seconds (3) and most of the CAD 
false marks could be easily dismissed. The average reading 
time per CAD mark is usually between 5 to 8 seconds (3, 
16).
Detection of Malignant Nodules
The ultimate task of CAD in the detection of lung nodules 
A B 
Fig. 2. Examples of isolated (A) and 
vascular-attached (B) nodules detected by 
computer-aided diagnosis system.Korean J Radiol 12(2), Mar/Apr 2011 www.kjronline.org 148
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is whether this approach can enhance the observers’ 
performance for detecting malignant lung nodules (17). Li 
et al. (18) performed an observer study to evaluate whether 
a CAD scheme can help radiologists detect the peripheral 
lung cancers missed at low-dose CT and they showed that 
the use of CAD could improve radiologists’ performance 
for detecting subtle cancers. In that study, 17 cases with 
missed peripheral lung cancer and 10 control cases were 
included. The cases with coexisting benign nodules were 
excluded. When CAD was applied in the patients who 
underwent metastasectomy, the sensitivity increased 
signifi  cantly from 86-91% to 94-95% for detecting 
malignant nodules (5). In another study by Goo et al. (4), 
the effect of CAD on the observer’s performance using a 
database that included normal cases, benign nodule cases 
and cases with lung cancers was evaluated. The database 
consisted of 150 CT scans that included 352 nodules and 
23 lung cancers. The readers were asked to record the 
likelihood of the presence of a nodule and the likelihood 
of malignancy separately. This study showed that the use 
of CAD contributed to the detection of additional lung 
cancers by less experienced readers. Yet on the statistical 
analysis, while the detection of nodule was signifi  cantly 
increased, the cancer detection rate was not signifi  cantly 
increased. These results indicate that another scheme 
of characterization in addition to nodule detection may 
be necessary to achieve the ultimate goal of detecting 
malignant nodules.
Scanning and Reconstruction Parameters of CT Scanning
Several technical aspects of CT scanning are related to 
the performance of CAD. The use of a narrow collimation 
with reconstructions of thin sections signifi  cantly improves 
the detection of nodule, and CAD is not recommended for 
CTs 4 mm or greater in section thickness (19, 20). 
Another technical aspect to consider is the effect of 
radiation exposure on automated lung nodule detection 
with using ultra-low-dose CT (21, 22). In a study by Lee 
et al. (21), 25 volunteers underwent CT scans using four 
different tube currents of 32, 16, 8, and 4 mAs. Although 
the sensitivities for detecting nodule decreased with 
reducing the tube currents, there were no signifi  cant 
differences in nodule detectability between the scans at 16 
mAs or 8 mAs versus those at 32 mAs. Hein et al. (22) also 
compared the performance of two CAD systems at different 
CT levels of 75 mAs and 5 mAs. For both CAD systems there 
were no signifi  cant differences between the detection rates 
for the standard and ultra-low-dose data sets.
Mode of Computer-Aided Diagnosis Reading
There are several ways to use CAD: as a fi  rst reader, as 
a second reader and as a concurrent reader. Because the 
sensitivity of the current CAD systems is not quite good 
enough, if radiologists only reviewed the CAD marks, then 
many nodules can be missed. So, this option of using CAD 
as a fi  rst reader cannot be considered for clinical practice at 
this time. As a concurrent reader (reading the CT scans with 
CAD marks displayed), it may be able to help save time, 
Fig. 4. Example of ground-glass nodule detected by computer-
aided diagnosis system.
Fig. 3. Example of false-positive detection by computer-aided 
diagnosis due to mucus within bronchus.Korean J Radiol 12(2), Mar/Apr 2011 www.kjronline.org 149
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but some nodules can still be missed. As discussed above, 
many studies have shown increased observer performance 
by using a CAD system as a second reader. In a study by 
Beyer et al. (23), the sensitivity of reading with CAD as 
a second reader was signifi  cantly higher than that with 
reading without CAD or with CAD as a concurrent reader, 
although the reading time was signifi  cantly shorter for the 
concurrent reading (274 seconds) as compared to that with 
reading without CAD (294 seconds) and that with CAD as 
a second reader (337 seconds). Given the overall moderate 
sensitivities of the CAD systems that are currently available, 
it is clear that CAD should be considered only as a second 
reader.
Detection of Ground-Glass Nodules
The likelihood of malignancy for ground-glass nodules 
(GGN) is much higher than that for solid nodules. In a 
study by Henschke et al. (24), 63% of the partly solid 
nodules and 18% of the nonsolid nodules were malignant 
as oppose to only 7% of the solid nodules. Despite this 
clinical signifi  cance, detecting GGNs is not an easy task 
due to their low contrast compared to the background. In 
addition, in the early developing stages of CAD, most CAD 
schemes were solely focused on detecting solid nodules. The 
fi  rst CAD scheme for the automated detection of GGNs was 
reported by Kim et al. (25), and those researchers used the 
texture features and Gaussian curve fi  tting features. More 
recently, Yanagawa et al. (26) evaluated the performance 
of a commercial CAD system for the detection of GGNs, 
and the sensitivity of GGN for radiologists (60-80%) was 
signifi  cantly higher than that for the CAD system (21%). 
Currently, the CAD system can only play a complementary 
role in detecting GGNs (Fig. 4).
Nodule Volumetry
Prediction of Nodule Malignancy
Computer-aided volumetry provides more accurate and 
reproducible measurement of nodules than does human 
observation for predicting the likelihood of malignancy and 
A B
Fig. 5. Examples of excellent (A) 
and satisfactory but not perfect (B) 
segmentation in nodule volumetry. Color 
overlay of B shows that part of nodule 
in contact with pleura is incompletely 
segmented.Korean J Radiol 12(2), Mar/Apr 2011 www.kjronline.org 150
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for monitoring the response of the tumor to treatment. 
Although the number of cases was small, it has been 
suggested that nodule malignancy could be identifi  ed 
based on the changes of the nodule volume. In a study by 
Yankelevitz et al. (27), all fi  ve malignant nodules out of 13 
nodules that were evaluated showed doubling times less 
than 177 days, and in a study by Revel et al. (28), nine 
malignant nodules among the 22 evaluated nodules showed 
a doubling time ranging from 37 to 216 days. In a separate 
study that evaluated 63 nodules, when the upper value of 
500 days for the doubling time of malignancy was applied, 
the sensitivity and specifi  city of the volumetric software 
for diagnosing malignancy were 91% and 90%, respectively 
(29). This study stressed that automated nodule volumetry 
provided a high negative predictive value of 98% for the 
diagnosis of malignant lung nodules.
Sources of Measurement Variability
After much early enthusiasm, many studies have revealed 
that there are many sources of variability in volumetric 
measurements, including the size and characteristics of 
nodules, the scan and reconstruction parameters of the CT 
examinations and the patient-related factors.
The estimate of nodule volume was then based on the 
total number of voxels within the segmented region. It 
can be predicted that the percentage of partial volume 
voxels decreases as the nodule size increases and as the 
section thickness decreases. For relatively small nodules 
that have no contact with the surrounding structures, 
section thickness is one of the most important factors 
because by decreasing the section thickness the partial 
volume effect of the surface voxels of a nodule is decreased. 
Therefore, obtaining CT scans with thin volumetric data is 
very important for nodule volumetry. Many studies have 
demonstrated that section thickness has a signifi  cant 
effect on nodule volumetry (30-35). In a phantom study 
by Goo et al. (30), statistically signifi  cant effects could be 
demonstrated for the segmentation threshold, the section 
thickness and the interaction of the threshold and section 
thickness. The effect of the fi  eld of view was not reported 
to be signifi  cant on volumetric measurements in several 
studies (30, 35, 36).
Nodule size is an important factor in determining 
measurement error as smaller nodules have a larger 
proportion of surface voxels, which result in an increased 
number of voxels that are affected by the partial volume 
effect. In a phantom study, the absolute percentage of 
error of nodule volumetry progressively increased with the 
decreasing nodule size (30). A similar effect of increased 
variability in volumetric measurement for decreasing nodule 
size was also reported in clinical studies (33).
As the size of the nodule increases, the nodules 
eventually grow to come into contact with the surrounding 
vessels and pleura. The resulting nodule attachment makes 
it diffi  cult to accurately defi  ne a nodule’s boundaries 
and therefore to segment a nodule from the background. 
Segmentation of a nodule from the adjacent structures can 
be challenging and it may lead to differences in a nodule’s 
volume. In a phantom study by Das et al. (32), the absolute 
percentage of volume error for pleural nodules was very 
high compared to that for other types of nodules. Even 
for expert radiologists, there was considerable variability 
on how to draw the boundary of a nodule, with the 
interobserver variability accounting for 40% of the total 
volume variability (37). In a study by de Hoop et al. (38), 
the segmentation accuracy was evaluated using six software 
packages for nodule volumetry. When a threshold of 20% 
in volume for the maximum mismatch between the overlay 
provided by a software package and the visual assessment 
was applied, the software packages provided adequate 
segmentation for 71% to 86% of the nodules.
With regard to radiation exposure, two studies that 
compared the measurement error between low-dose and 
standard-dose techniques showed different results (32, 39). 
While the bias error was signifi  cantly smaller for a 120 mAs 
scan than that for a 20 mAs scan in a study by Ko et al. (39), 
a study by Das et al. (32) showed no signifi  cant effect on 
the volumetric measurement error between the low-dose (20 
mAs) and standard-dose (100 mAs) protocols.  
Volumetric measurements of lung nodules can be 
signifi  cantly affected by changes in the lung volume (40, 
41). A study by Goo et al. (40) showed that the mean 
percent difference in lung nodule volume was 23% between 
the CT scans obtained at inspiration and expiration. In 
another study, a 17% mean change in lung nodule volume 
was observed between the CT scans obtained at the total 
lung capacity and at the residual volume (41). Although 
the differences in the lung volumes on the inspiration and 
expiration scans used in those studies are larger than those 
typically expected on routine follow-up clinical CT scans, 
respiration-related variability in measurements should also 
be a consideration in determining the true growth of a lung 
nodule.
When six software packages for nodule volumetry were Korean J Radiol 12(2), Mar/Apr 2011 www.kjronline.org 151
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compared using the same dataset, there were signifi  cant 
systemic differences of the mean volumes in 11 of the 15 
possible pairs of software packages (38). Therefore, the 
absolute nodule volumes provided by different software 
should not be compared.
Range of Measurement Variability
Because obtaining ground truth on nodule volume in vivo 
is a diffi  cult task, research has been focused on evaluating 
the precision or reproducibility of such measurements, 
or whether a true change of the nodule volume can be 
determined. 
In an early phantom study, the measurement variability 
for a synthetic nodule volume was reported to be as small 
as 3% (27). Yet in that study, the target nodules were 
solid, homogeneous, synthetic nodules without vascular 
attachment and they had a mean attenuation of 175 HU 
(Hounsfi  eld unit). Measuring this variability is hard to 
do in an in vivo study. In a study that evaluated stable 
nodules during a 2-year observation period, the standard 
measurement error in nodules 2-5 mm, 5-8 mm and 8-10 
mm in size was 19%, 11% and 7%, respectively (42). 
Based on these results, Kostis et al. (42) suggested that 
the critical time to perform follow-up for nodules with 
initial sizes of 2, 5, 8 and 10 mm as detected at baseline 
screening should be 12, 5, 3 and 1 month, respectively. 
Furthermore, as the measured difference includes both 
the true nodule change and variability due to measurement 
errors, the most essential question may be how we can 
identify the threshold for classifying the changes in volume 
as being medically meaningful. To address the issue of 
measurement variability, several studies that employed a 
same-day repeat CT protocol in patients with lung nodules  
(38, 43-46) have been conducted (Table 2). In one study, 
Wormanns et al. (43) reported that the 95% limits of 
agreement were -20% to 22%, and the subsequent studies 
showed that the 95% confi  dence intervals for the difference 
in measured volumes were up to 26%. These results indicate 
that an increase in measured volume by 25% has a 95% 
likelihood of refl  ecting true nodule growth rather than 
measurement variability. 
Volumetry in Assessing the Response to Treatment
Assessing the response to treatment has remained 
predominantly qualitative with performing manual 
measurements on a single two-dimensional image. However, 
it has been suggested that changes in tumor volume could 
be detected more sensitively than the changes in the 
conventional unidimensional measurements after targeted 
therapy for lung cancer (47). With regard to the accurate 
assessment of tumor response to therapy in clinical 
trials, inaccuracy in the manual measurements of tumor 
dimensions has been shown to signifi  cantly infl  uence the 
assessment of tumor response (48). Thus, a comparison 
between automated volumetry and manual measurements 
was performed by Marten et al. (49) and in their study, 
while there were no discrepancies of the assessments of 
patients’ response between the observers and the readings 
using volumetry, 24% of the patients received discordant 
response classifi  cations when manual measurements were 
used.
The use of quantitative volumetric CT may be able to 
reduce the number of total subjects enrolled in a clinical 
trial and the length of time an individual needs to be 
followed to reliably establish the treatment response by 
increasing the analytic power per subject enrolled in clinical 
trials (50).
Volume Measurement of Ground-Glass Nodules 
Most of the reported volumetric methods have been 
Table 2. Summary of Published Interscan Variability of Same-Day CT Scans for Making Volumetric Measurements 
Author (Reference No.) Year No. of Nodules Mean Nodule Size
† Section Thickness 95% Limit of Agreement
Wormanns et al. (43) 2004 151 7.4 mm (2.2-20.5 mm) 1.25 mm -20~22%
Goodman et al. (45) 2006 43
345.5 mm
3 
(49.3-1434 mm
3)
1.25 mm -26~26%
Gietema et al. (46) 2007 218
123 mm
3 
(16.4-472.7 mm
3)
1 mm -21~24%
de Hoop et al. (38) 2009 214 10.9 mm (3.3-30 mm) 1 mm    16~22%*
Zhao et al. (44) 2009 32 38.2 mm (10.6-92.7 mm) 1.25 mm -12~13%
Note.— *Upper limits of agreements from six software packages. 
†numbers in parentheses are size range. No. = numberKorean J Radiol 12(2), Mar/Apr 2011 www.kjronline.org 152
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focused on solid lung nodules and not on GGNs due to 
the low contrast of GGNs compared to that of the lung 
parenchyma. As such, the absolute volumetric error values 
for GGNs are known to be higher than that for solid 
nodules (39). Only a few studies regarding the volumetry 
of GGNs have been reported thus far due to the diffi  culty 
of measuring the volume of GGNs. When computer-aided 
volumetry was applied to nodules 8 mm or larger, the 95% 
limits of intraobserver agreement for the measurement of 
the same nodules were from 15% to 17% and those for the 
interobserver agreement were up to 24% (51). The interscan 
variability of nodule volumetry for GGNs in a same-day 
repeat CT study was reported to be up to 19% (52).
In addition, as tumors manifesting as GGNs show lepidic 
growth (53), determining the growth of GGNs based on 
the conventional diameter or volume measurements may 
not be appropriate. A different approach for determining 
the growth of GGN has recently been proposed. In one 
such phantom study, Lee et al. (54) reported that the 
amount of soft tissue of a nodule (volume × [1 + mean 
attenuation value/1000]) showed a strong correlation 
with the reference-standard amount of soft tissue. In 
a clinical evaluation study, de Hoop et al. (38) also 
reported that GGN mass measurements showed the smallest 
measurement variability compared to of the diameter and 
volume measurements. This mass measurement method 
was suggested to detect the growth of GGN earlier (425 
days) than that of the diameter (715 days) or volume 
measurements (673 days).
Application of Nodule Volumetry in Screening Trials
In the NELSON (Nederlands-Leuvens Longkanker 
Screenings Onderzoek) randomized lung cancer screening 
trial, the nodule management protocol was based on 
volumetric nodule assessment and the presence or 
absence of growth (55). Based on the studies in which 
the measurement variation was evaluated on the same day 
CT scans (43, 45, 46), growth was defi  ned as an increase 
in volume of at least 25% between the two scans. In the 
case of partly solid nodules, only the volume of the solid 
region was used. In the cases of pleural-based nodules, 
the diameter was measured at a point perpendicular to the 
costal pleura. A test was considered to be positive if a solid 
component of a nodule was more than 500 mm
3 (> 9.8 mm 
in diameter). If the solid component of a nodule was 50 
to 500 mm
3 (4.6 to 9.8 mm in diameter), then the volume 
doubling time was calculated with a 3-month follow-up CT 
scan, and if the volume-doubling time was less than 400 
days, then the nodule was considered to be positive. 
Morphologic Analysis of Lung Nodules
Conventionally, the likelihood of a nodule being malignant 
is usually suggested according to visual assessment by 
experienced radiologists through morphologic analysis 
of the nodule. In a study that evaluated 80 GGNs, the CT 
predictors of malignancy for GGNs included a size greater 
than 8 mm and a lobulated border for pure GGNs, and only a 
lobulated border for mixed GGNs (56). Studies that focused 
on observer performance have been conducted to evaluate 
whether computerized schemes can help radiologists 
distinguish benign from malignant nodules on CT (57, 58). In 
a study by Li et al. (57), the computerized output generated 
from 56 morphologic features and two clinical datasets 
were provided to 16 radiologists, and their performance 
was improved with the aid of the CAD scheme. In another 
study by Awai et al. (58), the computerized output was 
generated from the morphologic features of density, shape, 
the calcifi  cation volume and the cavity volume, and the use 
of the CAD system signifi  cantly improved the diagnostic 
performance of radiology residents, while it did not improve 
that of the board-certifi  ed radiologists for assessing the 
malignancy of lung nodules.
Follow-Up Registration and Nodule Matching
Comparison of serial CT scans to evaluate the growth 
and shrinkage of lung nodules is a routine clinical task 
in chest radiology. This process is typically performed by 
manually matching two series of images and it is quite time 
consuming. On the basis of the improved registration of 
images, automated computer assessment may provide the 
opportunity to rapidly identify and compare nodules over 
time to detect changes in size. Lee et al. (59) evaluated the 
performance of automated matching software for patients 
with metastatic lung nodules by using two serial CT scans 
with a 5-mm section thickness. The overall matching rate 
was 67%, and the matching rate was highly associated with 
changes in the lung confi  guration between two series of 
CT scans. The matching rate was higher (82%) for patients 
with a relatively unchanged lung confi  guration, compared 
to that (29%) for patients with substantial interval changes 
(59). In screening settings, the interval change of the lung 
confi  guration is usually less than that in oncologic settings, Korean J Radiol 12(2), Mar/Apr 2011 www.kjronline.org 153
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and the matching rates were reported to be 91% to 93% (3, 
60).
Summary and Perspective
The goal of CAD is to improve the radiologic interpretation 
of nodules, and many studies to date have shown that CAD 
can indeed improve radiologists’ performance for detecting 
lung nodules and that CAD should be used as a second 
reader. It also has been shown that nodule malignancy and 
the response of malignant lung tumors to treatment can 
be assessed by using nodule volumetry and that CAD has 
the potential to provide objective analysis of the nodule 
morphology and thereby enhance the workfl  ow when 
assessing follow-up studies. 
From a technical point of view, the application of CAD 
systems for nodule detection and volumetry should be 
performed using thin-section volumetric CT datasets. CT 
scans should also be obtained with the same protocol 
that is used for the nodule volumetry, and experts should 
carefully review the segmentation results (Fig. 5). As 
most clinicians are not familiar with quantitative results 
that are expressed as volumes, nodule size also needs to 
be reported as the effective diameter. An algorithm may 
be taken into consideration to predict the optimal time 
to wait for the follow-up scan according to the size of a 
nodule. Furthermore, every radiologist who clinically uses a 
CAD scheme should remember that CAD schemes do indeed 
miss lung nodules and there is considerable variability 
in computer-aided volumetry. Although only the CAD 
applications in nodule evaluation were discussed in this 
review article, by using the volumetric CT data and CAD 
schemes, a global approach when performing chest imaging 
is possible. Applying CAD to the assessment of the extent 
of emphysema and the airway dimensions as well as nodule 
evaluation is an example of using CAD in a lung cancer 
screening setting or for patient with chronic obstructive 
lung disease. CAD outputs can serve as important imaging 
biomarkers and they should be interpreted within the 
clinical context. Systems that support clinical decision 
making, such as using the clinical data and molecular 
biomarkers in addition to the computerized output based on 
imaging data, will surely be developed in the near future.
Although many studies have been performed to identify 
the potential application of CAD to chest CT, these efforts 
have not reached the stage of daily routine use in the 
clinical fi  eld. The performance of CAD still needs to be 
further improved for detecting nodules. In addition, 
streamlining the workfl  ow in CAD is important and a CAD 
workstation needs to start processing as soon as the CT 
data is generated. Subsequent integration of the data into 
a PACS can greatly enhance the radiologists’ workfl  ow (17), 
and a thin-client approach in which computing is performed 
in a separate server may be a potential solution. 
Although many obstacles remain to be overcome, CAD will 
eventually serve as an everyday tool for the interpretation 
of chest CT images. To achieve this goal, it is necessary 
not only to develop better CAD algorithms, but also to 
investigate how we can apply and optimize the effect of 
the computer output in clinical practice. 
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